Cutaneous T-cell Lymphoma
About
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | CD30 + | Cutaneous T-cell Lymphoma | Brentuximab Vedotin | |
| Sensitivity (+) | CD30 + | Cutaneous T-cell Lymphoma | Brentuximab Vedotin |